1. No sanctions for Novartis as FDA ends review of gene therapy violations— Medtronic makes plans for a ventilator open-source— COVID could cause 'digital reset' for pharma — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Central Pharmaceuticals

Anonymous board for Central Pharmaceuticals


Sort By:
Title ↓
Replies Views
Last Message
  1. Anonymous
    Replies:
    11
    Views:
    6,147
  2. Walking Eagle
    Replies:
    1
    Views:
    3,514
  3. Anonymous
    Replies:
    4
    Views:
    3,538
  4. Anonymous
    Replies:
    0
    Views:
    3,209
  5. Anonymous
    Replies:
    2
    Views:
    4,997
  6. Anonymous
    Replies:
    5
    Views:
    4,281

Thread Display Options

Loading...